TLC to Present at Upcoming Virtual Investor ConferencesDownload
TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that the Company’s management team will be presenting at the following virtual investor conferences:
HC Wainwright & Co Global Life Sciences Conference (March 9-10, 2021)
Oppenheimer 31st Annual Healthcare Conference (March 16-17, 2021)
The management team will also be participating in one-on-one meetings during the conference. The corporate presentation will be available on the TLC website at www.tlcbio.com in the Investors section, under News & Events.